A Phase 3 interventional study of Stannous fluoride and Sodium monofluorophosphate in Dentine Hypersensitivity, sponsored by GlaxoSmithKline. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-01-26.
Sponsored by GlaxoSmithKline · Phase 3, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 28 studies in Dentin Sensitivity by GlaxoSmithKline — none open to participants now, none under way, none of them phase 3. Dentin Sensitivity · GlaxoSmithKline.
Among the 28 studies in Dentin Sensitivity by GlaxoSmithKline, this one is the 22nd largest by enrollment, is the only one that started in 2013, is one of 5 in phase 3, and was the 6th registered.
290 studies on the registry are indexed under Dentin Sensitivity; 48 are open to participants now.
Browse Dentin Sensitivity studies →None of the 28 studies in Dentin Sensitivity by GlaxoSmithKline is open now. The open studies under Dentin Sensitivity, anywhere →
Of the 19 Dentin Sensitivity studies recruiting now, 6 (32%) set no upper age limit and 12 (63%) stop at 75 or younger; 1 takes children under 18; 11 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
28 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 1 started in 2013.
This study's enrollment of 119 is above the median of 60 across 281 interventional studies indexed under Dentin Sensitivity.
Median enrollment 164 across the 28 interventional studies. Of the 27 that completed or were terminated, 27 (100%) have results posted.
This tab as a report to print or save as PDF → With an account.
GlaxoSmithKline is the lead sponsor of 3,650 studies on the registry; 117 are open to participants now.
Of its 265 completed or terminated interventional studies of FDA-regulated products, 241 (91%) have results posted.
None of the studies under way reaches primary completion within a year.
Among the 28 studies in Dentin Sensitivity by GlaxoSmithKline, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Clinical studies have demonstrated long term relief from dentine hypersensitivity with twice daily brushing of a toothpaste containing stannous fluoride in comparison to marketed (negative) controls. The aim of this study is to evaluate the effectiveness of a stannous fluoride dentifrice in the treatment of dentinal hypersensitivity compared to a marketed (negative) control, over a period of 56 days (8 weeks) with twice daily brushing.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
At screening, a minimum of two accessible teeth (incisors, canines, premolars) that meet all of the following criteria.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants to brush whole mouth with 1-inch strip of the test dentifrice (0.454% SnF) for one timed minute, followed by rinsing with 5 milliliter (mL) of water.
Drug: Stannous fluoride
Participants to brush whole mouth with 1-inch strip of the control dentifrice (0.76% NaMFP) for one timed minute, followed by rinsing with 5 mL of water.
Drug: Sodium monofluorophosphate
Test dentifrice containing 0.454% SnF
Control dentifrice containing 0.76% w/w Sodium Monofluorophosphate \[1000 parts per million (ppm) fluoride\]
Mean Change From Baseline in Schiff Sensitivity Score
The examiner conducted the evaporative air sensitivity assessment and scored the subject's response to the sensitivity stimulus using the four-point categorical Schiff Sensitivity Scale (SSS). Score 0 = Subject does not respond to air stimulus Score 1 = Subject responds to air stimulus, but does not request discontinuation of stimulus Score 2 = Subject responds to air stimulus, and requests discontinuation or moves from stimulus Score 3 = Subject responds to air stimulus, considers stimulus to be painful, and requests discontinuation
Time frame: Baseline-Week 8
Mean Change From Baseline in Schiff Sensitivity Score
The examiner conducted the evaporative air sensitivity assessment and scored the subject's response to the sensitivity stimulus using the four-point categorical Schiff Sensitivity Scale (SSS). Score 0 = Subject does not respond to air stimulus Score 1 = Subject responds to air stimulus, but does not request discontinuation of stimulus Score 2 = Subject responds to air stimulus, and requests discontinuation or moves from stimulus Score 3 = Subject responds to air stimulus, considers stimulus to be painful, and requests discontinuation
Time frame: Baseline-Week 4
Mean Change From Baseline in Tactile Sensitivity
The examiner assessed the tactile sensitivity of eligible teeth using a Yeaple probe. The constant pressure applied by Yeaple probe probe allowed the examiner to vary the force applied to the dentin surface from 10g to an upper threshold of 80g, in increments of 10g. The greater the pressure the participant was able to tolerate, the less sensitive the tooth was considered. Testing began at 10g and increased by 10g, with each successive challenge, until either a "yes" response (pain was elicited) was recorded or the maximum force has been reached.
Time frame: Baseline-Week 8
Mean Change From Baseline in Tactile Sensitivity
The examiner assessed the tactile sensitivity of eligible teeth using a Yeaple probe. The constant pressure applied by Yeaple probe probe allowed the examiner to vary the force applied to the dentin surface from 10g to an upper threshold of 80g, in increments of 10g. The greater the pressure the participant was able to tolerate, the less sensitive the tooth was considered. Testing began at 10g and increased by 10g, with each successive challenge, until either a "yes" response (pain was elicited) was recorded or the maximum force has been reached.
Time frame: Baseline-Week 4
Mean Change in Dentinal Hypersensitivity After 4 Weeks as Measured by Visual Analog Scale (VAS)
The subject rated the intensity of their response to the evaporative air stimulus by rating the intensity of their response to the stimulus using a 100 millimeter (mm )VAS Scale 0 is No Pain and 100 is Worst Pain Imaginable A trained member of staff measured the line segment marked off in mm and recorded this measurement in the CRF
Time frame: Baseline-Week 4
Mean Change in Dentinal Hypersensitivity After 8 Weeks as Measured by Visual Analog Scale (VAS)
The subject rated the intensity of their response to the evaporative air stimulus by rating the intensity of their response to the stimulus using a 100 millimeter (mm )VAS Scale 0 is No Pain and 100 is Worst Pain Imaginable A trained member of staff measured the line segment marked off in mm and recorded this measurement in the CRF
Time frame: Baseline - Week 8
Participants were recruited at the clinical site.
| Milestone | Control Dentifrice (0.76% Sodium Monofluorophosphate) | Test Dentifrice (0.454% Stannous Fluoride) |
|---|---|---|
| Started | 60 | 59 |
| Completed | 57 | 56 |
| Not completed | 3 | 3 |
| Withdrew: Withdrawal of consent | 3 | 2 |
| Withdrew: Lost to follow-up | 0 | 1 |
The examiner conducted the evaporative air sensitivity assessment and scored the subject's response to the sensitivity stimulus using the four-point categorical Schiff Sensitivity Scale (SSS). Score 0 = Subject does not respond to air stimulus Score 1 = Subject responds to air stimulus, but does not request discontinuation of stimulus Score 2 = Subject responds to air stimulus, and requests discontinuation or moves from stimulus Score 3 = Subject responds to air stimulus, considers stimulus to be painful, and requests discontinuation
| Score on a scale | Control Dentrifice (0.76% Sodium Monofluorophosphate) | Test Dentrifice (0.454% Stannous Fluoride) |
|---|---|---|
| Schiff Sensitivity Score at Baseline | 2.26 ± 0.379 | 2.25 ± 0.355 |
| Schiff Sensitivity Score at Week 8 | 2.09 ± 0.628 | 0.78 ± 0.687 |
The examiner conducted the evaporative air sensitivity assessment and scored the subject's response to the sensitivity stimulus using the four-point categorical Schiff Sensitivity Scale (SSS). Score 0 = Subject does not respond to air stimulus Score 1 = Subject responds to air stimulus, but does not request discontinuation of stimulus Score 2 = Subject responds to air stimulus, and requests discontinuation or moves from stimulus Score 3 = Subject responds to air stimulus, considers stimulus to be painful, and requests discontinuation
| Score on a Scale | Control Dentrifice (0.76% Sodium Monofluorophosphate) | Test Dentrifice (0.454% Stannous Fluoride) |
|---|---|---|
| Schiff Sensitivity Score at Baseline | 2.26 ± 0.379 | 2.25 ± 0.355 |
| Schiff Sensitivity Score at Week 4 | 2.10 ± 0.601 | 1.27 ± 0.598 |
The examiner assessed the tactile sensitivity of eligible teeth using a Yeaple probe. The constant pressure applied by Yeaple probe probe allowed the examiner to vary the force applied to the dentin surface from 10g to an upper threshold of 80g, in increments of 10g. The greater the pressure the participant was able to tolerate, the less sensitive the tooth was considered. Testing began at 10g and increased by 10g, with each successive challenge, until either a "yes" response (pain was elicited) was recorded or the maximum force has been reached.
| Grams | Control Dentrifice (0.76% Sodium Monofluorophosphate) | Test Dentrifice (0.454% Stannous Fluoride) |
|---|---|---|
| Tactile Threshold at Baseline (g) | 10.1 ± 0.66 | 10.4 ± 1.43 |
| Tactile Threshold at Week 8 (g) | 14.6 ± 13.77 | 41.6 ± 25.85 |
The examiner assessed the tactile sensitivity of eligible teeth using a Yeaple probe. The constant pressure applied by Yeaple probe probe allowed the examiner to vary the force applied to the dentin surface from 10g to an upper threshold of 80g, in increments of 10g. The greater the pressure the participant was able to tolerate, the less sensitive the tooth was considered. Testing began at 10g and increased by 10g, with each successive challenge, until either a "yes" response (pain was elicited) was recorded or the maximum force has been reached.
| Grams | Control Dentrifice (0.76% Sodium Monofluorophosphate) | Test Dentrifice (0.454% Stannous Fluoride Dentifrice) |
|---|---|---|
| Tactile Thresold (g) at Baseline | 10.1 ± 0.66 | 10.4 ± 1.43 |
| Tactile Thresold (g) at Week 4 | 15.8 ± 14.78 | 24.6 ± 17.53 |
The subject rated the intensity of their response to the evaporative air stimulus by rating the intensity of their response to the stimulus using a 100 millimeter (mm )VAS Scale 0 is No Pain and 100 is Worst Pain Imaginable A trained member of staff measured the line segment marked off in mm and recorded this measurement in the CRF
| Score on a Scale | Control Dentrifice (0.76% Sodium Monofluorophosphate) | Test Dentrifice (0.454% Stannous Fluoride) |
|---|---|---|
| VAS Score at Baseline | 58.40 ± 21.661 | 58.26 ± 21.099 |
| VAS Score at week 4 | 50.32 ± 23.257 | 38.09 ± 21.612 |
The subject rated the intensity of their response to the evaporative air stimulus by rating the intensity of their response to the stimulus using a 100 millimeter (mm )VAS Scale 0 is No Pain and 100 is Worst Pain Imaginable A trained member of staff measured the line segment marked off in mm and recorded this measurement in the CRF
| Score on a Scale | Control Dentrifice (0.76% Sodium Monofluorophosphate) | Test Dentrifice (0.454% Stannous Fluoride) |
|---|---|---|
| VAS Score at Baseline | 58.40 ± 21.661 | 58.26 ± 21.099 |
| VAS Score at Week 8 | 43.94 ± 23.996 | 22.17 ± 22.299 |
Collected over All Adverse events encountered or spontaneously reported following use of dentifices were reported at Baseline visit(Visit 2), 28 days(Visit 3) and Visit 4(Day 56). Non-serious events are listed at a 1% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Control Dentifrice (0.76% Sodium Monofluorophosphate) | — | 0/60 (0%) | 2/60 (3.3%) |
| Test Dentifrice (0.454% Stannous Fluoride) | — | 0/59 (0%) | 1/59 (1.7%) |
| Event | Control Dentifrice (0.76% Sodium Monofluorophosphate) | Test Dentifrice (0.454% Stannous Fluoride) |
|---|---|---|
| DysgeusiaGeneral disorders | 0/60 | 1/59 |
| Mouth InjuryGeneral disorders | 1/60 | 0/59 |
| InfluenzaRespiratory, thoracic and mediastinal disorders | 1/60 | 0/59 |
| Age, Continuous(Years) | Control Dentifrice (0.76% Sodium Monofluorophosphate) | Test Dentifrice (0.454% Stannous Fluoride) | Total |
|---|---|---|---|
| Mean | 43.1 ± 12.27 | 42.2 ± 11.27 | 42.6 ± 11.73 |
| Sex: Female, Male(Participants) | Control Dentifrice (0.76% Sodium Monofluorophosphate) | Test Dentifrice (0.454% Stannous Fluoride) | Total |
|---|---|---|---|
| Female | 43 ± 75.4 | 46 ± 80.7 | 89 |
| Male | 14 ± 24.6 | 11 ± 19.3 | 25 |
The record gives a start of Feb 2013, a primary completion of May 2013 and a completion of May 2013. It does not say whether these dates are actual or estimated.
Results were first posted in Jan 2015, 1 year 8 months after primary completion.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jan 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Tin Fluorides